MedPlus Health Services (MEDPLUS) Stock Overview
Engages in the retail trading of medicines and general items in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for MEDPLUS from our risk checks.
MEDPLUS Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
MedPlus Health Services Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹816.15 |
| 52 Week High | ₹1,045.30 |
| 52 Week Low | ₹642.00 |
| Beta | 0.55 |
| 1 Month Change | 7.44% |
| 3 Month Change | -2.69% |
| 1 Year Change | -3.39% |
| 3 Year Change | 17.71% |
| 5 Year Change | n/a |
| Change since IPO | -27.20% |
Recent News & Updates
Is MedPlus Health Services Limited (NSE:MEDPLUS) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 29
MedPlus Health Services Limited Just Beat EPS By 13%: Here's What Analysts Think Will Happen Next
Nov 05Recent updates
Is MedPlus Health Services Limited (NSE:MEDPLUS) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 29MedPlus Health Services Limited Just Beat EPS By 13%: Here's What Analysts Think Will Happen Next
Nov 05MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital Not Reflecting Well On The Business
Sep 25Earnings Beat: MedPlus Health Services Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 06Market Participants Recognise MedPlus Health Services Limited's (NSE:MEDPLUS) Earnings
Jul 16₹1,053 - That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After These Results
May 31Here's What's Concerning About MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital
May 18MedPlus Health Services Limited's (NSE:MEDPLUS) P/E Still Appears To Be Reasonable
Mar 26
Opening 600 New Stores And Improving Operations Will Expand Future Market Reach
Expansion with new warehouses and 600 stores will enhance supply chain, boost revenue, and drive significant top-line growth.MedPlus Health Services Limited (NSE:MEDPLUS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Feb 05A Look At The Fair Value Of MedPlus Health Services Limited (NSE:MEDPLUS)
Jan 28Even With A 27% Surge, Cautious Investors Are Not Rewarding MedPlus Health Services Limited's (NSE:MEDPLUS) Performance Completely
Dec 05There Are Reasons To Feel Uneasy About MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital
Aug 30Is Now The Time To Put MedPlus Health Services (NSE:MEDPLUS) On Your Watchlist?
Feb 03MedPlus Health Services (NSE:MEDPLUS) Will Want To Turn Around Its Return Trends
Dec 11A Look At The Intrinsic Value Of MedPlus Health Services Limited (NSE:MEDPLUS)
Oct 24The Returns On Capital At MedPlus Health Services (NSE:MEDPLUS) Don't Inspire Confidence
Jul 18Why Investors Shouldn't Be Surprised By MedPlus Health Services Limited's (NSE:MEDPLUS) P/S
Jun 22A Look At The Fair Value Of MedPlus Health Services Limited (NSE:MEDPLUS)
Apr 18MedPlus Health Services (NSE:MEDPLUS) Could Be Struggling To Allocate Capital
Feb 08₹1,177: That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After Its Latest Results
Jun 03Shareholder Returns
| MEDPLUS | IN Consumer Retailing | IN Market | |
|---|---|---|---|
| 7D | 0.4% | -2.2% | -1.4% |
| 1Y | -3.4% | 1.8% | -3.8% |
Return vs Industry: MEDPLUS underperformed the Indian Consumer Retailing industry which returned 1.8% over the past year.
Return vs Market: MEDPLUS matched the Indian Market which returned -3.8% over the past year.
Price Volatility
| MEDPLUS volatility | |
|---|---|
| MEDPLUS Average Weekly Movement | 3.9% |
| Consumer Retailing Industry Average Movement | 5.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in IN Market | 8.5% |
| 10% least volatile stocks in IN Market | 3.0% |
Stable Share Price: MEDPLUS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: MEDPLUS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 25,007 | Gangadi Reddy | www.medplusindia.com |
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres.
MedPlus Health Services Limited Fundamentals Summary
| MEDPLUS fundamental statistics | |
|---|---|
| Market cap | ₹97.87b |
| Earnings (TTM) | ₹1.95b |
| Revenue (TTM) | ₹62.93b |
Is MEDPLUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDPLUS income statement (TTM) | |
|---|---|
| Revenue | ₹62.93b |
| Cost of Revenue | ₹46.84b |
| Gross Profit | ₹16.09b |
| Other Expenses | ₹14.14b |
| Earnings | ₹1.95b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 16.28 |
| Gross Margin | 25.57% |
| Net Profit Margin | 3.10% |
| Debt/Equity Ratio | 0% |
How did MEDPLUS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/11 11:51 |
| End of Day Share Price | 2025/12/11 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MedPlus Health Services Limited is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vijayaraghavan Swaminathan | Avendus Spark |
| Harith Ahamed | Avendus Spark |
| null null | Axis Capital Limited |